Shantha Kodihalli

Sr Director, Preclinical Research, R & d @Emergent BioSolutions

Winnipeg, MB, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2022 — Present

Sr Director, Preclinical Research, R & d @Emergent BioSolutions

View department →

EDUCATION

N/A

University of Minnesota-Twin Cities

PhD

N/A

University of Agricultural Sciences, Bangalore

BVSc, MVSc

SKILLS

MicrobiologyVaccinesImmunoassaysTherapeuticsLife SciencesAnimal ModelsGood Laboratory Practice (Glp)BiotechnologyProtein PurificationAntibodiesVirologyBiochemistryInfectious DiseasesDrug DiscoveryRegulatory AffairsLifesciencesRegulatory SubmissionsIn VivoElisaPharmaceutical IndustryFdaU.s. Food and Drug Administration (Fda)Drug DevelopmentClinical DevelopmentImmunologyAssay DevelopmentProtein ChemistryCell CultureIndMolecular BiologyVaccineGlpCell

ABOUT SHANTHA KODIHALLI

R and D executive with 20 years of experience in leading preclinical programs including the development and characterization of animal models, advancement of vaccine and therapeutic against infectious agents, and progressing medical countermeasures for licensure by the FDA Animal Rule. Primary specialization is in animal models, vaccines and therapeutics for inhalational anthrax, botulism, small pox, Ebola, pandemic and avian flu, and acute radiation syndromes.Accomplished in FDA Animal Rule; Good Laboratory Practices; animal models of infectious disease and acute radiation syndromes; medical countermeasure development for licensure under the Animal rule; pre-IND and IND briefing packages; BLA preparations for submission for both Animal rule and traditional licensure pathways for biologicals; government contracting; contract research organization oversight.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Shantha Kodihalli — Sr Director, Preclinical Research, R & d at Emergent BioSolutions in Winnipeg, MB, CA | Unifers